Qianjiang Yongan Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was CNY 311.17 million compared to CNY 412.21 million a year ago. Revenue was CNY 311.17 million compared to CNY 412.21 million a year ago.

Net income was CNY 14.98 million compared to CNY 50.59 million a year ago. Basic earnings per share from continuing operations was CNY 0.0508 compared to CNY 0.1649 a year ago. Diluted earnings per share from continuing operations was CNY 0.0508.